The largest purchase of all time was on 2017-05-30 and amounted to 23000 shares of Alnylam Pharmaceuticals, Inc. for $1.5M.
The largest sale of all time was on 2017-12-01 and amounted to 60000 shares of Alnylam Pharmaceuticals, Inc. for $8.15M.
No biography is available at this moment.
| 2022-05-16 | Immuneering Corporation IMRX | 7,000 0.0283% | $5.00 | $35,000 | +42.64% | |||
| 2022-05-06 | PepGen Inc. PEPG | director | 4,166 0.0275% | $12.00 | $49,992 | -7.45% | ||
| 2021-08-05 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 10,000 0.0082% | $188.95 | $1.89M | -16.25% | |
| 2021-08-03 | Immuneering Corporation IMRX | director | 7,000 0.03% | $15.00 | $105,000 | -47.84% | ||
| 2021-07-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 6,812 0.0058% | $178.96 | $1.22M | -6.34% | |
| 2021-06-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 1,734 0.0014% | $154.00 | $267,036 | +8.21% | |
| 2021-01-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 9,027 0.0077% | $169.90 | $1.53M | +0.06% | |
| 2021-01-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 14,941 0.0123% | $160.20 | $2.39M | +3.25% | |
| 2021-01-11 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 758 0.0006% | $154.00 | $116,732 | +9.19% | |
| 2020-07-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 47,250 0.0429% | $160.67 | $7.59M | -8.35% | |
| 2020-04-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 10,000 0.0083% | $139.00 | $1.39M | -3.95% | |
| 2020-02-10 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 10,000 0.0087% | $129.00 | $1.29M | +3.18% | |
| 2020-01-29 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 6,337 0.0057% | $119.00 | $754,103 | +13.32% | |
| 2020-01-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Legal Officer | 41,037 0.0366% | $117.70 | $4.83M | +13.95% | |
| 2018-06-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, GC & Secretary | 3,126 0.0022% | $73.63 | $230,167 | -19.92% | |
| 2018-03-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, GC & Secretary | 3,124 0.0032% | $149.83 | $468,066 | -37.94% | |
| 2018-03-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, GC & Secretary | 20,000 0.0158% | $113.70 | $2.27M | -35.36% | |
| 2018-03-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, GC & Secretary | 20,000 0.0153% | $108.70 | $2.17M | -34.34% | |
| 2017-12-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, GC & Secretary | 12,498 0.0129% | $121.20 | $1.51M | -18.45% | |
| 2017-12-01 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, GC and Secretary | 60,000 0.0618% | $135.89 | $8.15M | -26.51% |